表紙
市場調査レポート

抗菌コーティングの世界市場予測 2020年:金属コーティング・非金属コーティング・カテーテル・埋め込み型装置・手術器具

Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 339445
出版日 ページ情報 英文 162 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
抗菌コーティングの世界市場予測 2020年:金属コーティング・非金属コーティング・カテーテル・埋め込み型装置・手術器具 Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020
出版日: 2015年09月07日 ページ情報: 英文 162 Pages
概要

医療関連感染 (HAI) のリスク増加により、抗菌コーティングの需要が大きく拡大しています。材料種類別では、金属コーティング区分が2015年における最大の区分になると見込まれています。しかし、非金属区分は同年において最も最長が速い区分になると予測されています。機器種類別では、カテーテル区分が2015年における最大の区分になると見込まれています。しかし、埋め込み型装置区分は同年において最も最長が速い区分になると予測されています。地域別では2015年において北米が最大のシェアを構成し、欧州、アジア太平洋、およびその他地域 (ROW) が続く見込みです。今後数年のうちに、インド、中国および日本の重視により、アジア地域において最も高い成長率が予測されています。

当レポートでは、世界の抗菌コーティング市場について調査し、市場概要、材料種類・機器の種類・地域別の市場分析と予測、競合環境の分析、および市場参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の医療機器向け抗菌コーティング市場の概要
  • 世界の医療機器向け抗菌コーティング市場:材料タイプ別
  • 医療機器向け抗菌コーティング市場の地域分析:機器の種類別
  • 医療機器向け金属抗菌コーティング市場:種類別
  • 医療機器向け抗菌コーティング市場の地域別概要

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会
    • 緊急の課題

第6章 規制評価:抗菌コート医療機器

  • イントロダクション
  • 米国
  • 欧州
  • 日本
  • 中国
  • インド
  • オーストラリア

第7章 医療機器向け抗菌コーティング市場:材料種類別

  • イントロダクション
  • 金属コーティング
    • 銀コーティング
    • 銅コーティング
    • その他の金属コーティング
  • 非金属コーティングコーティング
    • ポリマーコーティング
    • 有機系コーティング

第8章 医療機器向け抗菌コーティング市場:機器の種類別

  • イントロダクション
  • カテーテル
  • 埋め込み型装置
  • 手術器具
  • その他

第9章 医療機器向け抗菌コーティング市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (ROW)

第10章 競合環境

  • 概要
  • 競合状況・動向
  • 成長戦略の実験的評価
  • 競合発展マッピング

第11章 企業プロファイル (概要、財務、製品&サービス、および発展動向)

  • イントロダクション
  • BASF SE
  • COVALON TECHNOLOGIES LTD.
  • ROYAL DSM
  • THE DOW CHEMICAL COMPANY
  • HYDROMER, INC.
  • PPG INDUSTRIES, INC.
  • AST PRODUCTS, INC.
  • BIOINTERACTIONS LTD
  • SCIESSENT LLC
  • SPECIALTY COATING SYSTEMS, INC.

第12章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3715

Over the years, the medical devices manufacturers are looking for antimicrobial coatings which are biocompatible, non-toxic, and biostable for a wide range of medical devices. The demand for these antimicrobial coatings has increased significantly, owing to the increasing risk of hospital-associated infections (HAI's).

Based on the type of material, the global antimicrobial coatings for medical devices market is segmented into metallic coatings and non-metallic coatings. The metallic coatings segment is expected to be the largest segment in 2015. However, the non-metallic segment is expected to be the fastest growing segment in 2015. The metallic segment is further sub-segmented into silver coatings, copper coatings and other metallic coatings which include zinc and titanium. The silver coatings segment is expected to be the largest and fastest-growing segment in 2015. The non-metallic segment is further sub-segmented into polymeric coatings and organic coatings. The polymeric coatings segment is expected to be the largest and fastest-growing segment in 2015.

Based on the devices type, the global antimicrobial coatings for medical devices market is segmented into catheters, implantable devices, surgical instruments, and other devices (Mandrels & Molds, Guidewires, Epidural Needles, and Elastomeric Seals). The catheters segment is expected to be the largest segment in 2015. However, implantable device segment is expected to be the fastest growing segment in 2015.

North America is expected to account for the largest share of the global antimicrobial coatings for medical devices market for medical devices, followed by Europe, Asia-Pacific, and Rest of the world (RoW) in 2015. In the coming years, the antimicrobial coatings for medical devices market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of antimicrobial coatings.

The global antimicrobial coatings companies adopt various strategies (agreements, partnerships, mergers, collaborations, acquisitions, new product launches, geographical expansions, acquisitions, certifications, and grants, among others) to increase their market shares and establish a strong foothold in the global antimicrobial coatings market for medical devices.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps companies, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the antimicrobial coatings for medical devices market. The report analyzes the antimicrobial coatings market by type of material and devices type
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the antimicrobial coatings for medical devices market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various antimicrobial coating technologies across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the antimicrobial coatings for medical devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the antimicrobial coatings for medical devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET BREAKDOWN AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW OF GLOBAL ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES
  • 4.2. GLOBAL ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY TYPE OF MATERIAL
  • 4.3. GEOGRAPHIC ANALYSIS OF THE ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY DEVICE TYPE
  • 4.4. METALLIC ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY TYPE
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising awareness about hospital-acquired infections
      • 5.2.1.2. Favorable research and funding environment
        • 5.2.1.2.1. Grants by Australian government to the University of New South Wales
        • 5.2.1.2.2. Funding by the European Union for projects on antimicrobial resistance FP5-FP7
        • 5.2.1.2.3. Funding by Innovate UK for Accentus Medical's antimicrobial project
        • 5.2.1.2.4. Grant by the European Commission to the Institute of Biomaterial
        • 5.2.1.2.5. Funding by the European Union for the NOMORFILM consortium
        • 5.2.1.2.6. Grants by Small Business Innovation Research (SBIR) for ISurTec's antimicrobial technologies
      • 5.2.1.3. Technological advancements in antimicrobial coatings
        • 5.2.1.3.1. Parylene technology by Specialty Coating Systems
        • 5.2.1.3.2. Nanocomposite coating technology by the University of Dundee (U.K.)
        • 5.2.1.3.3. Novel coating technology by the University of South Australia
      • 5.2.1.4. Growing implantable devices market
      • 5.2.1.5. Increasing research and development activities for antimicrobial coated cardiovascular devices
      • 5.2.1.6. High growth in geriatric population
      • 5.2.1.7. Increasing burden of cardiovascular diseases across the globe
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Limitations of silver ion coatings
      • 5.2.2.2. Presence of time- and resource-intensive processes for development and approval of antimicrobial coating products
      • 5.2.2.3. Unfavorable healthcare reforms in the U.S.
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing healthcare market in emerging economies
      • 5.2.3.2. Increasing number of Free Trade Agreements
    • 5.2.4. BURNING ISSUES
      • 5.2.4.1. Lack of FDA guidelines and regulations for antimicrobial coating techniques

6. REGULATORY ASSESSMENT- ANTIMICROBIAL COATED MEDICAL DEVICES

  • 6.1. INTRODUCTION
  • 6.2. U.S.
    • 6.2.1. INTRODUCTION
    • 6.2.2. FDA DEVICES CLASSIFICATION
    • 6.2.3. THE REGULATORY PROCESS
    • 6.2.4. THE U.S. REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.2.5. MAJOR HURDLE IN THE REGULATORY PROCESS
  • 6.3. EUROPE
    • 6.3.1. INTRODUCTION
    • 6.3.2. ENVIRONMENTAL PROTECTION AGENCY (EPA) DEVICES CLASSIFICATION
    • 6.3.3. THE REGULATORY PROCESS
    • 6.3.4. EUROPEAN REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.3.5. MAJOR HURDLE IN THE REGULATORY PROCESS
  • 6.4. JAPAN
    • 6.4.1. INTRODUCTION
    • 6.4.2. PMDA DEVICES CLASSIFICATION
    • 6.4.3. THE REGULATORY PROCESS
    • 6.4.4. JAPANESE REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.4.5. MAJOR HURDLE IN THE REGULATORY PROCESS
  • 6.5. CHINA
    • 6.5.1. INTRODUCTION
    • 6.5.2. CFDA DEVICES CLASSIFICATION
    • 6.5.3. THE REGULATORY PROCESS
    • 6.5.4. CHINESE REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.5.5. MAJOR HURDLE IN THE REGULATORY PROCESS
  • 6.6. INDIA
    • 6.6.1. INTRODUCTION
    • 6.6.2. THE REGULATORY PROCESS
    • 6.6.3. INDIAN REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.6.4. MAJOR HURDLE IN THE REGULATORY PROCESS
  • 6.7. AUSTRALIA
    • 6.7.1. INTRODUCTION
    • 6.7.2. ATG DEVICES CLASSIFICATION
    • 6.7.3. THE REGULATORY PROCESS
    • 6.7.4. AUSTRALIAN REGULATORY APPROVAL TIMELINE ASSESMENT
    • 6.7.5. MAJOR HURDLE IN THE REGULATORY PROCESS

7. ANTIMICROBIAL COATING MARKET FOR MEDICAL DEVICES, BY TYPE OF MATERIAL

  • 7.1. INTRODUCTION
  • 7.2. METALLIC COATINGS
    • 7.2.1. SILVER COATINGS
    • 7.2.2. COPPER COATINGS
    • 7.2.3. OTHER METALLIC COATINGS
  • 7.3. NON-METALLIC COATINGS
    • 7.3.1. POLYMERIC COATINGS
    • 7.3.2. ORGANIC COATINGS

8. ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY DEVICE TYPE

  • 8.1. INTRODUCTION
  • 8.2. CATHETERS
  • 8.3. IMPLANTABLE DEVICES
  • 8.4. SURGICAL INSTRUMENTS
  • 8.5. OTHER DEVICES

9. ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Rising prevalence of hospital-acquired infections in the U.S.
      • 9.2.1.2. Development of newer technologies by U.S. companies
      • 9.2.1.3. Stringent regulations on antimicrobial-coated medical devices in the U.S.
      • 9.2.1.4. Growing number of cardiovascular diseases
      • 9.2.1.5. Rising prevalence of chronic diseases and increasing aging population in the U.S.
      • 9.2.1.6. Rising prevalence of diabetes in the U.S. to drive the market for diabetic foot medical equipment
    • 9.2.2. CANADA
      • 9.2.2.1. Growing medical devices industry in Canada
      • 9.2.2.2. Rising incidences of hospital-acquired infections in Canada
  • 9.3. EUROPE
    • 9.3.1. INCREASING FUNDING FOR ANTIMICROBIAL COATINGS IN EUROPE
    • 9.3.2. RAPIDLY AGING POPULATION IN EUROPE
    • 9.3.3. GERMANY
      • 9.3.3.1. Expansions and innovations in antimicrobial coatings
      • 9.3.3.2. The growing medical device industry in Germany
      • 9.3.3.3. Rising cases of hip and knee replacement in Germany
    • 9.3.4. U.K.
      • 9.3.4.1. Research activities in the U.K.
    • 9.3.5. FRANCE
      • 9.3.5.1. Rising prevalence of diabetes
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC
    • 9.4.1. INCREASING NUMBER OF HOSPITALS IN INDIA AND CHINA
    • 9.4.2. JAPAN
      • 9.4.2.1. Japan's growing healthcare industry
    • 9.4.3. CHINA
      • 9.4.3.1. Growing number of cardiovascular diseases and increasing aging population
      • 9.4.3.2. Licensing agreement and expansion strategies adopted by coating manufacturers in China
      • 9.4.3.3. China's increasing demand for high-quality medical devices
    • 9.4.4. INDIA
      • 9.4.4.1. Increasing number of endoscopic surgeries
      • 9.4.4.2. Increasing geriatric population in India
    • 9.4.5. REST OF ASIA-PACIFIC (ROAPAC)
      • 9.4.5.1. Increasing research activities in Singapore & Australia
      • 9.4.5.2. Indonesian medical devices market faces stringent regulations
  • 9.5. REST OF THE WORLD (ROW)
      • 9.5.1.1. Increasing aging population and the subsequent rise in age-related disorders in the Middle East
      • 9.5.1.2. Favorable business environment in Middle East
      • 9.5.1.3. Rising obesity in Mexico, Chile, Panama, Argentina, and Costa Rica
      • 9.5.1.4. The healthcare system in Brazil offers various opportunities for medical device manufacturers
      • 9.5.1.5. Market scenario in Argentina, Latin America, and South Africa

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATION AND TRENDS
    • 10.2.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.2.2. EXPANSION
    • 10.2.3. MARKETING & PROMOTION
    • 10.2.4. OTHERS
  • 10.3. EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
    • 10.3.1. ROUTE TO GROWTH: ORGANIC VS INORGANIC STRATEGIES
      • 10.3.1.1. Organic Growth Strategies
      • 10.3.1.2. Inorganic Growth Strategies
  • 10.4. COMPETITIVE DEVELOPMENTS MAPPING

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. BASF SE
  • 11.3. COVALON TECHNOLOGIES LTD.
  • 11.4. ROYAL DSM
  • 11.5. THE DOW CHEMICAL COMPANY
  • 11.6. HYDROMER, INC.
  • 11.7. PPG INDUSTRIES, INC.
  • 11.8. AST PRODUCTS, INC.
  • 11.9. BIOINTERACTIONS LTD
  • 11.10. SCIESSENT LLC
  • 11.11. SPECIALTY COATING SYSTEMS, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2012-2015)
    • 12.2.1. SPECIALTY COATINGS SYSTEM, INC.
    • 12.2.2. HYDROMER, INC.
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORT

LIST OF TABLES

  • TABLE 1: RISING AWARENESS ABOUT HOSPITAL-ACQUIRED INFECTIONS IS PROPELLING THE GROWTH OF THIS MARKET
  • TABLE 2: LIMITATIONS OF SILVER ION COATINGS RESTRAIN THE GROWTH OF THIS MARKET
  • TABLE 3: THE GROWING HEALTHCARE MARKET IN EMERGING REGIONS TO OFFER HUGE OPPORTUNITY FOR THE MARKET
  • TABLE 4: LACK OF FDA GUIDELINES AND REGULATIONS FOR ANTIMICROBIAL COATINGS TECHNIQUES- A BURNING ISSUE
  • TABLE 5: GLOBAL ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 6: GLOBAL METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 7: GLOBAL METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL SILVER ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL COPPER ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL OTHER METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: GLOBAL NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 12: GLOBAL NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: POLYMERS USED FOR MEDICAL DEVICES
  • TABLE 14: GLOBAL POLYMERIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL ORGANIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 17: ANTIMICROBIAL COATINGS MARKET SIZE FOR CATHETERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: ANTIMICROBIAL COATINGS MARKET SIZEFOR IMPLANTABLE DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: ANTIMICROBIAL COATINGS MARKET SIZE FOR SURGICAL INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: ANTIMICROBIAL COATINGS MARKET SIZE FOR OTHER DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NORTH AMERICA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 24: NORTH AMERICA: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: NORTH AMERICA: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 26: NORTH AMERICA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 27: U.S.: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 28: U.S.: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 29: U.S.: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: U.S.: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: CANADA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 32: CANADA: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 33: CANADA: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: CANADA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 35: EUROPE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: EUROPE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 37: EUROPE: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: EUROPE: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 39: EUROPE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: GERMANY: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 41: GERMANY: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: GERMANY: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: GERMANY: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: U.K.: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 45: U.K.: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: U.K.: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: U.K.: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: FRANCE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 49: FRANCE: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: FRANCE: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: FRANCE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: ROE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 53: ROE: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 54: ROE: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: ROE: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: JAPAN: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 62: JAPAN: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: JAPAN: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: JAPAN: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: CHINA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 66: CHINA: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: CHINA: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: CHINA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: INDIA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 70: INDIA: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: INDIA: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: INDIA: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 73: ROAPAC: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 74: ROAPAC: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 75: ROAPAC: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 76: ROAPAC: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 77: ROW: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE OF MATERIAL, 2013-2020 (USD MILLION)
  • TABLE 78: ROW: METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 79: ROW: NON-METALLIC ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 80: ROW: ANTIMICROBIAL COATINGS MARKET SIZE FOR MEDICAL DEVICES, BY DEVICE TYPE, 2013-2020 (USD MILLION)
  • TABLE 81: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2014
  • TABLE 82: EXPANSIONS, 2012-2014
  • TABLE 83: MARKETING & PROMOTION, 2012-2014
  • TABLE 84: RECENT DEVELOPMENTS, 2012-2014

LIST OF FIGURES

  • FIGURE 1: ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES SEGMENTATION
  • FIGURE 2: GLOBAL ANTIMICROBIAL COATINGS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: NON-METALLIC COATINGS SEGMENT TO WITNESS HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 9: SILVER COATINGS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 10: POLYMERIC COATING SEGMENT TO GROW AT THE HIGHER CAGR DURING THE FORECAST PERIOD
  • FIGURE 11: IMPLANTABLE DEVICES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 12: ASIA-PACIFIC SLATED TO WITNESS THE HIGHEST GROWTH IN THE ANTIMICROBIAL COATINGS MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: ATTRACTIVE OPPORTUNITIES IN THE ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES
  • FIGURE 14: NON-METALLIC COATINGS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: NORTH AMERICA TO DOMINATE THE ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY DEVICE TYPE
  • FIGURE 16: SILVER COATINGS SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 17: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020
  • FIGURE 18: ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES: DRIVERS, RESTRAINS, OPPORTUNITIES, & BURNING ISSUES
  • FIGURE 19: THE U.S. REGULATORY PROCESS
  • FIGURE 20: REGULATORY APPROVAL TIMELINE - U.S.
  • FIGURE 21: EUROPEAN REGULATORY PROCESS
  • FIGURE 22: REGULATORY APPROVAL TIMELINE - EUROPE
  • FIGURE 23: JAPANESE REGULATORY PROCESS
  • FIGURE 24: REGULATORY APPROVAL TIMELINE - JAPAN
  • FIGURE 25: CHINESE REGULATORY PROCESS
  • FIGURE 26: REGULATORY APPROVAL TIMELINE - CHINA
  • FIGURE 27: REGULATORY PROCESS IN INDIA
  • FIGURE 28: REGULATORY APPROVAL TIMELINE - INDIA
  • FIGURE 29: AUSTRALIAN REGULATORY PROCESS
  • FIGURE 30: REGULATORY APPROVAL TIMELINE - AUSTRALIA
  • FIGURE 31: GLOBAL ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY TYPE
  • FIGURE 32: NON-METALLIC COATINGS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 33: SILVER COATINGS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 34: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 35: POLYMERIC COATINGS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 36: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 37: GLOBAL ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES, BY DEVICE TYPE
  • FIGURE 38: IMPLANTABLE DEVICES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 39: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE GLOBAL ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES IN 2015
  • FIGURE 40: THE U.S. TO WITNESS THE HIGHEST GROWTH IN THE NORTH AMERICAN ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES (2015)
  • FIGURE 41: GERMANY TO WITNESS THE HIGHEST GROWTH IN THE EUROPEAN ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES (2015)
  • FIGURE 42: JAPAN TO WITNESS THE HIGHEST GROWTH IN THE ASIA-PACIFIC ANTIMICROBIAL COATINGS MARKET FOR MEDICAL DEVICES (2015)
  • FIGURE 43: GEOGRAPHIC SNAPSHOT: ROW
  • FIGURE 44: AGREEMENTS, COLLABORATIONS & PARTNERSHIPS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS IN THE MARKET
  • FIGURE 45: ORGANIC GROWTH STRATEGIES, BY KEY PLAYERS (2012-2015)
  • FIGURE 46: INORGANIC GROWTH STRATEGIES, BY KEY PLAYERS (2012-2015)
  • FIGURE 47: MAPPING OF TOP 10 PLAYERS FOR EACH KEY GROWTH STRATEGY (2012-2015)
  • FIGURE 48: GEOGRAPHICAL REVENUE MIX OF TOP PLAYERS
  • FIGURE 49: BASF SE: COMPANY SNAPSHOT
  • FIGURE 50: COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT
  • FIGURE 51: ROYAL DSM: COMPANY SNAPSHOT
  • FIGURE 52: THE DOW CHEMICAL COMPANY.: COMPANY SNAPSHOT
  • FIGURE 53: HYDROMER, INC.: COMPANY SNAPSHOT
  • FIGURE 54: PPG INDUSTRIES, INC.: COMPANY SNAPSHOT
Back to Top